Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 74

1.

Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.

Bernardo M, Cañas F, Herrera B, García Dorado M.

Rev Psiquiatr Salud Ment. 2016 Jun 9. pii: S1888-9891(16)30016-7. doi: 10.1016/j.rpsm.2016.04.001. [Epub ahead of print] English, Spanish.

2.

Knowledge management through two virtual communities of practice (Endobloc and Pneumobloc).

Lara B, Cañas F, Vidal A, Nadal N, Rius F, Paredes E, Hernández M, Maravall FJ, Franch-Nadal J, Barbé F, Mauricio D.

Health Informatics J. 2016 Apr 21. pii: 1460458216639739. [Epub ahead of print]

PMID:
27102887
3.

Nurses' perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey.

Emsley R, Alptekin K, Azorin JM, Cañas F, Dubois V, Gorwood P, Haddad PM, Naber D, Olivares JM, Papageorgiou G, Roca M, Thomas P, Hargarter L, Schreiner A; EMEA ADHES group..

Ther Adv Psychopharmacol. 2015 Dec;5(6):339-50. doi: 10.1177/2045125315612013.

4.

Epigenetics changes associated to environmental triggers in autoimmunity.

Cañas CA, Cañas F, Bonilla-Abadía F, Ospina FE, Tobón GJ.

Autoimmunity. 2016;49(1):1-11. doi: 10.3109/08916934.2015.1086996. Review.

PMID:
26369426
5.

Design, construction, and implementation of an online platform for patients with type 1 diabetes: EncoDiab.

Alvarado-Martel D, Cañas F, Velasco R, Alcubierre N, López-Ríos L, Rius F, Nóvoa FJ, Carrillo A, Hernández M, Wägner AM, Mauricio D.

Patient Prefer Adherence. 2015 Jun 15;9:767-75. doi: 10.2147/PPA.S77730.

6.

Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis.

Seret G, Cañas F, Pougnet-Di Costanzo L, Hanrotel-Saliou C, Jousse-Joulin S, Le Meur Y, Saraux A, Valeri A, Putterman C, Youinou P, Rojas-Villarraga A, Anaya JM, Renaudineau Y.

J Autoimmun. 2015 Jul;61:54-61. doi: 10.1016/j.jaut.2015.05.009.

PMID:
26071203
7.

Towards a pragmatic and operational definition of relapse in schizophrenia: A Delphi consensus approach.

San L, Serrano M, Cañas F, Romero SL, Sánchez-Cabezudo Á, Villar M.

Int J Psychiatry Clin Pract. 2015 Jun;19(2):90-8. doi: 10.3109/13651501.2014.1002501.

PMID:
25547440
8.

Annexin A2 autoantibodies in thrombosis and autoimmune diseases.

Cañas F, Simonin L, Couturaud F, Renaudineau Y.

Thromb Res. 2015 Feb;135(2):226-30. doi: 10.1016/j.thromres.2014.11.034. Review.

PMID:
25533130
9.

Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats.

Arango-Dávila CA, Vera A, Londoño AC, Echeverri AF, Cañas F, Cardozo CF, Orozco JL, Rengifo J, Cañas CA.

Int J Neurosci. 2015;125(12):936-40. doi: 10.3109/00207454.2014.980906.

PMID:
25350870
10.

Resistance to first-line antituberculosis drugs in Spain, 2010-2011. RETUBES Study.

Blanquer R, Rodrigo T, Casals M, Ruiz Manzano J, García-García JM, Calpe JL, Valencia E, Pascual T, Mir I, Jiménez MÁ, Cañas F, Vidal R, Penas A, Caylà JA; Working Group of the Integrated Programme for Research in Tuberculosis in Spain..

Arch Bronconeumol. 2015 Jan;51(1):24-30. doi: 10.1016/j.arbres.2014.06.001. English, Spanish.

11.

Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.

Cañas CA, Cañas F, Izquierdo JH, Echeverri AF, Mejía M, Bonilla-Abadía F, Tobón GJ.

J Clin Rheumatol. 2014 Apr;20(3):125-9. doi: 10.1097/RHU.0000000000000098.

PMID:
24662551
12.

Satisfaction with Life of Schizophrenia Outpatients and Their Caregivers: Differences between Patients with and without Self-Reported Sleep Complaints.

Brissos S, Afonso P, Cañas F, Bobes J, Bernardo Fernandez I, Guzman C.

Schizophr Res Treatment. 2013;2013:502172. doi: 10.1155/2013/502172.

13.

Treatment adherence and quality of sleep in schizophrenia outpatients.

Afonso P, Brissos S, Cañas F, Bobes J, Bernardo-Fernandez I.

Int J Psychiatry Clin Pract. 2014 Jan;18(1):70-6. doi: 10.3109/13651501.2013.845219.

PMID:
24047426
14.

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa.

Olivares JM, Alptekin K, Azorin JM, Cañas F, Dubois V, Emsley R, Gorwood P, Haddad PM, Naber D, Papageorgiou G, Roca M, Thomas P, Martinez G, Schreiner A.

Patient Prefer Adherence. 2013;7:121-32. doi: 10.2147/PPA.S37534.

15.

Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection.

Bonilla-Abadía F, Echeverri AF, Izquierdo JH, Cañas F, Cañas CA.

Case Rep Rheumatol. 2012;2012:923897. doi: 10.1155/2012/923897.

16.

Improving treatment adherence in your patients with schizophrenia: the STAY initiative.

Cañas F, Alptekin K, Azorin JM, Dubois V, Emsley R, García AG, Gorwood P, Haddad PM, Naber D, Olivares JM, Papageorgiou G, Roca M.

Clin Drug Investig. 2013 Feb;33(2):97-107. doi: 10.1007/s40261-012-0047-8. Review.

PMID:
23288695
17.

The cost-effectiveness of paliperidone extended release in Spain.

Treur M, Baca E, Bobes J, Cañas F, Salvador L, Gonzalez B, Heeg B.

J Med Econ. 2012;15 Suppl 1:26-34. doi: 10.3111/13696998.2012.734884.

PMID:
23016569
18.

Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?

Thabet Y, Cañas F, Ghedira I, Youinou P, Mageed RA, Renaudineau Y.

J Autoimmun. 2012 Sep;39(3):154-60. doi: 10.1016/j.jaut.2012.05.015. Review.

PMID:
22709855
19.

The biological significance of evolution in autoimmune phenomena.

Cañas CA, Cañas F.

Autoimmune Dis. 2012;2012:784315. doi: 10.1155/2012/784315.

20.

Rapid test for identification of a highly transmissible Mycobacterium tuberculosis Beijing strain of sub-Saharan origin.

Millán-Lou MI, Alonso H, Gavín P, Hernández-Febles M, Campos-Herrero MI, Copado R, Cañas F, Kremer K, Caminero JA, Martín C, Samper S.

J Clin Microbiol. 2012 Feb;50(2):516-8. doi: 10.1128/JCM.06314-11.

Items per page

Supplemental Content

Support Center